Sudthida Vasavanonda

3.1k total citations · 1 hit paper
27 papers, 2.1k citations indexed

About

Sudthida Vasavanonda is a scholar working on Infectious Diseases, Virology and Organic Chemistry. According to data from OpenAlex, Sudthida Vasavanonda has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 18 papers in Virology and 13 papers in Organic Chemistry. Recurrent topics in Sudthida Vasavanonda's work include HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (18 papers) and Click Chemistry and Applications (13 papers). Sudthida Vasavanonda is often cited by papers focused on HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (18 papers) and Click Chemistry and Applications (13 papers). Sudthida Vasavanonda collaborates with scholars based in United States, United Kingdom and Netherlands. Sudthida Vasavanonda's co-authors include Dale J. Kempf, Daniel W. Norbeck, Kennan C. Marsh, Akhteruzzaman Molla, Edith McDonald, Jon F. Denissen, Charles A. Flentge, Norman E. Wideburg, John M. Leonard and Ann Hsu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Biochemistry.

In The Last Decade

Sudthida Vasavanonda

27 papers receiving 2.0k citations

Hit Papers

Ordered accumulation of mutations in HIV protease confers... 1996 2026 2006 2016 1996 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
    1996 601 citations Akhteruzzaman Molla, Marina Korneyeva et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sudthida Vasavanonda United States 16 1.5k 1.3k 488 481 217 27 2.1k
J C Quintero United States 13 1.7k 1.1× 1.6k 1.3× 529 1.1× 352 0.7× 280 1.3× 19 2.3k
Yasuhiro Koh United States 27 1.7k 1.1× 1.6k 1.3× 787 1.6× 562 1.2× 383 1.8× 40 2.4k
Piet Wigerinck Belgium 19 1.1k 0.7× 768 0.6× 438 0.9× 439 0.9× 421 1.9× 44 1.8k
William E. Kohlbrenner United States 19 924 0.6× 695 0.6× 774 1.6× 521 1.1× 353 1.6× 34 1.9k
Joseph A. Martin United Kingdom 21 1.0k 0.7× 635 0.5× 784 1.6× 582 1.2× 388 1.8× 42 2.1k
W. Gary Tarpley United States 28 1.5k 1.0× 1.5k 1.2× 1.2k 2.4× 622 1.3× 289 1.3× 57 2.9k
Norman E. Wideburg United States 13 888 0.6× 710 0.6× 613 1.3× 603 1.3× 149 0.7× 29 1.5k
Lori J. Gabryelski United States 12 1.8k 1.2× 1.6k 1.3× 718 1.5× 464 1.0× 268 1.2× 16 2.2k
Jon F. Denissen United States 14 1.2k 0.8× 829 0.7× 390 0.8× 186 0.4× 158 0.7× 23 1.9k
Debananda Das United States 25 1.0k 0.7× 920 0.7× 489 1.0× 263 0.5× 299 1.4× 45 1.7k

Countries citing papers authored by Sudthida Vasavanonda

Since Specialization
Citations

This map shows the geographic impact of Sudthida Vasavanonda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sudthida Vasavanonda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sudthida Vasavanonda more than expected).

Fields of papers citing papers by Sudthida Vasavanonda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sudthida Vasavanonda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sudthida Vasavanonda. The network helps show where Sudthida Vasavanonda may publish in the future.

Co-authorship network of co-authors of Sudthida Vasavanonda

This figure shows the co-authorship network connecting the top 25 collaborators of Sudthida Vasavanonda. A scholar is included among the top collaborators of Sudthida Vasavanonda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sudthida Vasavanonda. Sudthida Vasavanonda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Chen, Hing L. Sham, Minghua Sun, et al.. (2005). Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strains. Bioorganic & Medicinal Chemistry Letters. 15(24). 5499–5503. 17 indexed citations
2.
Sham, Hing L., David A. Betebenner, William Rosenbrook, et al.. (2004). Novel lopinavir analogues incorporating heterocyclic replacements of six-member cyclic urea––synthesis and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 14(10). 2643–2645. 15 indexed citations
3.
Huang, Peggy, John T. Randolph, Larry L. Klein, et al.. (2004). Synthesis and antiviral activity of P1′ arylsulfonamide azacyclic urea HIV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(15). 4075–4078. 10 indexed citations
4.
Hickman, Dean, Sudthida Vasavanonda, Warren M. Kati, et al.. (2004). Estimation of Serum-Free 50-Percent Inhibitory Concentrations for Human Immunodeficiency Virus Protease Inhibitors Lopinavir and Ritonavir. Antimicrobial Agents and Chemotherapy. 48(8). 2911–2917. 24 indexed citations
5.
Chen, Xiaoqi, Dale J. Kempf, Hing L. Sham, et al.. (2003). Synthesis and SAR studies of potent HIV protease inhibitors containing novel dimethylphenoxyl acetates as P2 ligands. Bioorganic & Medicinal Chemistry Letters. 13(21). 3657–3660. 17 indexed citations
6.
Sham, Hing L., David A. Betebenner, Xiaoqi Chen, et al.. (2002). Synthesis and structure–activity relationships of a novel series of HIV-1 protease inhibitors encompassing ABT-378 (Lopinavir). Bioorganic & Medicinal Chemistry Letters. 12(8). 1185–1187. 14 indexed citations
7.
Sham, Hing L., Chen Zhao, Leping Li, et al.. (2002). Novel lopinavir analogues incorporating non-Aromatic P-1 side chains—Synthesis and structure–Activity relationships. Bioorganic & Medicinal Chemistry Letters. 12(21). 3101–3103. 41 indexed citations
8.
Molla, Akhteruzzaman, et al.. (2002). In Vitro Antiviral Interaction of Lopinavir with Other Protease Inhibitors. Antimicrobial Agents and Chemotherapy. 46(7). 2249–2253. 46 indexed citations
9.
Sham, Hing L., David A. Betebenner, Thomas Herrin, et al.. (2001). Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir). Bioorganic & Medicinal Chemistry Letters. 11(11). 1351–1353. 15 indexed citations
10.
Molla, Akhteruzzaman, Sudthida Vasavanonda, Gondi Kumar, et al.. (1998). Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus. Virology. 250(2). 255–262. 154 indexed citations
11.
Chen, Xiaoqi, Dale J. Kempf, Hing L. Sham, et al.. (1998). Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands. Bioorganic & Medicinal Chemistry Letters. 8(24). 3531–3536. 7 indexed citations
12.
Kempf, Dale J., Akhteruzzaman Molla, Kennan C. Marsh, et al.. (1997). Lack of stereospecificity in the binding of the P2 amino acid of ritonavir to HIV protease. Bioorganic & Medicinal Chemistry Letters. 7(6). 699–704. 4 indexed citations
13.
Molla, Akhteruzzaman, Marina Korneyeva, Qing Gao, et al.. (1996). Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nature Medicine. 2(7). 760–766. 601 indexed citations breakdown →
14.
Sham, Hing L., Chen Zhao, Kennan C. Marsh, et al.. (1995). Potent Inhibitors of the HIV-1 Protease with Good Oral Bioavailabilities. Biochemical and Biophysical Research Communications. 211(1). 159–165. 6 indexed citations
15.
Kempf, Dale J., Kent D. Stewart, Charles A. Flentge, et al.. (1994). Symmetry-Based Inhibitors of HIV Protease with Rigid P2 Amino Acid Mimics. Protein and Peptide Letters. 1(4). 223–230. 2 indexed citations
16.
Kempf, Dale J., Kennan C. Marsh, Hing L. Sham, et al.. (1994). Design of orally bioavailable, symmetry-based inhibitors of HIV protease. Bioorganic & Medicinal Chemistry. 2(9). 847–858. 40 indexed citations
17.
Sham, Hing L., David A. Betebenner, Norman E. Wideburg, et al.. (1993). Pseudo‐symmetrical difluoroketones. FEBS Letters. 329(1-2). 144–146. 12 indexed citations
18.
Kempf, Dale J., W E Kohlbrenner, Norman E. Wideburg, et al.. (1993). Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diol. Journal of Medicinal Chemistry. 36(3). 320–330. 107 indexed citations
19.
Sham, Hing L., David A. Betebenner, Norman E. Wideburg, et al.. (1991). Potent HIV-1 protease inhibitors with antiviral activities in vitro. Biochemical and Biophysical Research Communications. 175(3). 914–919. 17 indexed citations
20.
Kempf, Dale J., Daniel W. Norbeck, William E. Kohlbrenner, et al.. (1990). Structure-based, C2 symmetric inhibitors of HIV protease. Journal of Medicinal Chemistry. 33(10). 2687–2689. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J C Quintero Breakdown of academic impact, for papers by Yasuhiro Koh Breakdown of academic impact, for papers by Piet Wigerinck Breakdown of academic impact, for papers by William E. Kohlbrenner Breakdown of academic impact, for papers by Joseph A. Martin Breakdown of academic impact, for papers by W. Gary Tarpley Breakdown of academic impact, for papers by Norman E. Wideburg Breakdown of academic impact, for papers by Lori J. Gabryelski Breakdown of academic impact, for papers by Jon F. Denissen Breakdown of academic impact, for papers by Debananda Das
Rankless by CCL
2026